Fungi from mangrove have attracted much attention for their unique living conditions of wave-energy tidal mudflats, high moisture level, high salt concentration and lack of oxygen. 1) This fungal group has been widely recognized as rich source of active secondary metabolites. 2, 3) As part of our ongoing search for novel bioactive compounds from microorganisms isolated from unusual or specialized ecological niches, 4-6) the culture extract of a fungus strain (Aspergillus ustus), isolated from the rhizosphere soil of the mangrove Acrostichum aureurm grown in Guangxi Province of China, showed cytotoxic activity against P388 (mice lymphocytic leukemia) cell line. The chemical composition research on the EtOAc extract of the A. ustus fermentation led us to identify five new drimane sesquiterpenes (1-5) together with 14 known analogues ( Fig. 1 ). 1,7-12) Herein, we report the structural elucidations and cytotoxic activities of these metabolites against P388, HL-60 (human promyelocytic leukemia cells), K562 (human erythromyeloblastoid leukemia cells) and BEL-7402 (human hepatoma cells).
ration of H-5 and H-6 was trans. The cis configuration of H-11 and H-13 was deduced by the NOEs between H-13 and H-11. Thus, the overall relative configuration of compound 1 was analogous to albrassitriol (20), and we named this new metabolite O-methylalbrassitriol (1) . 13) Compound 2, obtained as a white powder, was assigned to have the molecular formula C 15 H 22 O 3 based on a HR-ESI-MS peak at m/z 249.1484 [MϪH] Ϫ , and thus possessing 5 degrees of unsaturation. The IR spectrum showed absorption bands at 3353, 1669 and 1713 cm Ϫ1 , indicating the presence of hydroxyl, conjugated carbonyl, and aldehyde functionalities. The 1D-NMR data (Tables 1, 2) of compound 2 showed that its structure was closely related to that of the isolated known compound 8, except for the absence of CH 2 OH-9 signals [d H 3.65 (1H, dd, Jϭ11.5, 4.4 Hz)/3.52 (1H, dd, Jϭ11.5, 4.9 Hz), 4.82 (1H, dd, Jϭ4.9, 4.4 Hz); d C 61.7 (t)], and the presence of NMR resonances typical for an aldehyde group [d H 9.81 (1H, s), d C 205.6 (d)], thus suggesting the replacement of the alcohol group in 8 by a aldehyde group in the new compound 2. This conclusion was also supported by the apparent downshifted C-9 (D 9.3 ppm), caused by the deshielding effect of the aldehyde functionality. A review of the structures for compounds 2, 8, 9-13, suggests that these metabolites likely share the same biogenetic origin. Thus, they are expected to have the same relative configuration, which is further supported by comparing their optical rotation values ([a] D 25 Ϫ40°for 8 vs Ϫ25°for 2). Therefore, the structure of 2 was determined as 9a-hydroxyl-9-formyl-5adrim-7-en-6-one.
Compound 3 was separated as a white powder. The molecular formula was established as C 15 (Fig. 2) represented three structural moieties, C-1 to C-3, C-6(OH) to C-7(OH) and C-11(OH) to C-11. The planar structure was determined by connecting these fragments based on the HMBC correlations from H-5 to C-1 and C-13 , from H-12 to C-7 and C-9, and from H-13 to C-1 and C-9.
The relative configuration of 3 was deduced from the NOESY experiment, coupling style and conformational analysis. The correlations between H-5 and H-15, H-6 and H-15, indicated an a configuration for H-5, H-6 and H-15. The b configuration of H-13 was deduced by the correlation between H-14 and H-13. The resonances of OH-6 and OH-7 in 1 H-NMR were doublets which indicated that these two hydroxyl protons are coupled with H-6 and H-7, respectively. The resonance assigned to H-7 was an broad doublet (Jϭ5.0 Hz) whereas the signal for H-6 turned out to be a broad apparent singlet, thus supporting the coupling of H-6 and H-7 with their neighboring hydroxyl group protons. The above analysis indicates that the coupling between H-6 and H-7 is negligible (if any) and thus, the dihedral angle between H-6 and H-7 must be nearly 90°. This suggests a trans configuration for H-6 and H-7 Hence, compound 3 was elucidated as drim-8-en-6b,7a,11-triol.
Compound 4 was obtained as a colorless oil, of which HR-ESI-MS data indicated the molecular formula as C 23 H 30 O 7 . Comparison of the 1D-NMR data with those of the compound 15 suggested that they shared a similar molecular scaffold with differences only on the side chain. The major distinction was the replacement of CH 2 -6Ј [d C 42.6 (t)/d H 2.22 (2H, m)] by CϭO [d C 201.8 (s)], in agreement with the downfield chemical shift of C-7Ј (D 2.1 ppm) caused by the deshielding effect of the carbonyl group, further confirmed by 1 H-1 H COSY and HMBC correlations (Fig. 2) .
The relative configuration of compound 4 was determined by NOESY correlations between H-6 and H-15, H-5 and H-15, H-5 and OH-9, which displayed cis-configurations of H-5, H-6 and OH-9. The configuration of C-10 was found the same as compound 15 by comparison of 13 C chemical shifts (d C 37.3 for 4 vs. d C 37.3 for 15). Thus, the structure of 4 was determined as (6-strobilactone-B) ester of (E,E)-6-carbonyl-7-hydroxy-2,4-octadienoic acid.
Compound 5 was isolated as a colorless oil, its HR-ESI-MS gave an exact mass of m/z 425.2302 for [MϩNa] ϩ , suggesting the molecular formula C 24 H 34 O 5 . The 1D-NMR data (Tables 1, 2) were similar to that of the known compound 18. 9) The main differences include the presence of an additional methoxy resonance [d H/C 3.29 (3H, s)/55.0 (q)], meanwhile carbons C-9, C-11 and C-12 were shifted downfield at 2.9, 5.5, and 6.8 ppm, respectively. The new methoxy group was allocated at C-11 based on the HMBC correlation between its protons and C-11. Therefore, the planar structure The planar structures of compounds 3 and 4 are already registered in CAS (CAS No.: 1217857-65-2 for 3 and 1217868-38-6 for 4). But to the best of our knowledge, there are no data and references available for them. Hence, we still regarded them as new compounds in this communication. The remaining known metabolites were identified by comparing their spectroscopic data with that reported in the literature. 1, [7] [8] [9] [10] [11] [12] All compounds were evaluated for their cytotoxicities against P388, HL-60, K562 and BEL-7402 cell lines using the sulforhodamine B (SRB) 14) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 14) methods. Only compound 4 exhibited moderate cytotoxicity against the P388 cell line with IC 50 value of 8.7 mM. The other compounds were inactive on the four cell lines mentioned above at a test concentration of 10 mM. Interestingly, the differences of cytotoxicities between compounds 4 and 15 on the P388 cell line indicated that the carbonyl at C-6Ј was necessary for 764 Vol. 59, No. 6 the activity. Drimane sesquiterpenoids are widely spread metabolites of terrestrial plants, marine animals, and fungi. To the best of our knowledge, natural drimanes containing a double bond between C-8 and C-9 are only found in terrestrial plants 15, 16) and oils. 17) Thus, compound 3 constitutes the first of such drimanes reported from a fungus. Metabolites 4, 5, 7 and 15-19 are drimane sesquiterpenoids esterified at C-6, which were found only in Aspergillus sp. until now. 1, [7] [8] [9] Due to their diverse biological activities, which include antifeedant, cytotoxic, and piscicidal among others, drimane sesquiterpenoids have attracted the attention of the synthetic community. 18) The biological evaluation on other bioassays of all compounds herein reported is still in progress.
Experimental
General Experimental Procedures Optical rotations were obtained on a JASCO P-1020 digital polarimeter (JASCO Inc., Tokyo, Japan). IR spectrum was taken on a Nicolet NEXUS 470 spectrophotometer (Thermo Electron Corporation, Madison, WI, U.S.A.) in KBr disks. 1 H-, 13 C-NMR and DEPT spectra and 2D-NMR were recorded on a JEOL JNMECP600 (JEOL Ltd., Tokyo, Japan) and Bruker DRX 400 (Bruker Ltd., Germany) spectrometers using TMS as internal standard, and chemical shifts were recorded as d values. ESI-MS were measured on a Q-TOF Ultima Global GAA076 LC mass spectrometer (Waters Corporation, Milford, MA, U.S.A.). Semipreparative HPLC was performed using an ODS column [YMC-pack ODS-A, 10ϫ250 mm, 5 mm, (YMC Co., Ltd., Kyoto, Japan), 4 ml/min]. TLC and column chromatography (CC) were performed on plates precoated with silica gel GF254 (10-40 mm) and over silica gel (200-300 mesh, Qingdao Marine Chemical Factory, Qingdao, China) and Sephadex LH-20 (GE Healthcare, Uppsala, Sweden), respectively.
Fungal Material The strain A. ustus was isolated from the rhizosphere soil of the mangrove plant Acrostichum aureurm grown in Guangxi Province of China. The voucher specimen is deposited in our laboratory at Ϫ20°C. The working strain was prepared on potato dextrose agar slants and stored at 4°C.
Fermentation, Extraction, and Isolation The fungus A. ustus was incubated for 11 d on a rotary shaker at 180 rpm at 28°C in two hundreds of 500 ml conical flasks containing liquid medium (150 ml/flask), composed of glucose (10.0 g/l), maltose (20.0 g/l), mannitol (20.0 g/l), monosodium glutamate (10.0 g/l), KH 2 PO 4 (0.5 g/l), MgSO 4 · 7H 2 O (0.3 g/l), corn steep liquor (1.0 g/l), yeast extract (3.0 g/l), and seawater after adjusting to pH 7.0. The fermented whole broth was filtered through cheese cloth to separate into supernatant and mycelia. The former was extracted three times with EtOAc, while the latter was extracted three times with acetone and concentrated under reduced pressure to afford an aqueous solution which was extracted three times with EtOAc. Both EtOAc solutions were combined and concentrated under reduced pressure to give the crude extract (95 g).
The crude extract was subjected to vacuum liquid chromatography over silica gel column using a gradient elution with petroleum ether (PE)/CH 2 Cl 2 / MeOH to give 6 fractions. Fraction 1 was chromatographed on a silica gel column, eluted with PE/EtOAc (1 : 1) to provide 3 subfractions (Fr. 1.1-Fr. 1.3). Compounds 7 (20 mg, t R 19.5 min) and 18 (25 mg, t R 12.2 min) were obtained from Fr. 1.2 by semipreparative HPLC eluting with 80% aqueous MeOH. Fraction 1.1 and Fr. 1.3 were further purified by semipreparative HPLC to give compounds 19 (7.8 mg, t R 15.7 min/85% aqueous MeOH) and 5 (3 mg, t R 10.7 min/80% aqueous MeOH), respectively. Fraction 2 was separated by Sephadex LH-20 eluting with CH 2 Cl 2 /MeOH (1 : 1) to provide 2 subfractions (Fr. 2.1 and Fr. 2.2). Fraction 2.1 was further fractionated by semipreparative HPLC to give compounds 10 (3 mg, t R 12.2 min/65% aqueous MeOH) and 1 (43 mg, t R 15.3 min/65% aqueous MeOH). Fraction 2.2 was rechromatographed on a silica gel column, eluted with PE/EtOAc (3 : 1), and on semipreparative HPLC to afford compound 16 (4 mg, t R 14.8 min/ 70% aqueous MeOH). Fraction 3 was chromatographed on a silica gel column using a step gradient elution of PE/acetone to provide 2 fractions, Fr. 3.1 and Fr. 3.2. The two fractions were further purified by semipreparative HPLC to give compounds 8 (5 mg, t R 11.5 min/55% aqueous MeOH) and 14 (29 mg, t R 13.8 min/65% aqueous MeOH), respectively. Fraction 5 was purified by sephadex LH-20, eluting with MeOH to provide 2 fractions, Fr. 5.1 and Fr. 5.2. Fr. 5.1 was chromatographed on a silica gel column using a step gradient elution of PE/acetone to provide 2 subfractions, Fr. 5.1.1 and Fr.
